Hypofractionated versus conventionally fractionated radiotherapy for patients with prostate cancer (HYPRO): acute toxicity results from a randomised non-inferiority phase 3 trial

Autor: Aluwini, Shafak, Pos, Floris, Schimmel, Erik, van Lin, Emile, Krol, Stijn, van der Toorn, Peter Paul, de Jager, Hanja, Dirkx, Maarten, Alemayehu, Wendimagegn Ghidey, Heijmen, Ben, Incrocci, Luca
Zdroj: In The Lancet Oncology March 2015 16(3):274-283
Databáze: ScienceDirect